（吉隆坡19日讯）兴业小盘东盟研究对LAC Med Bhd（KL:LACMED）展开研究，认为该股是马来西亚医疗保健现代化进程的代表股。

兴业投行研究首次追踪LAC Med（LACMED，5341，主板保健股），称该公司为大马医疗现代化的代表企业。...

RHB Small Cap Asean Research sees LAC Med Bhd (KL:LACMED) as a play on Malaysia’s healthcare modernisation, assigning an 13% upside in its initiation report on the company which was listed on the Main Market of Bursa Malaysia in December 2025.

UMediC Group Bhd (KL:UMC), through its wholly-owned subsidiary UWHM Sdn Bhd, has signed a lease agreement with Penang Development Corporation (PDC) for a 3.06-acre industrial parcel in Batu Kawan Industrial Park 3. According to a press release on Friday, the lease is valued at RM11.4 million and will span 60 years, with payments to be made in tranches.

KUALA LUMPUR: UMediC Group Bhd said its wholly-owned subsidiary UWHM Sdn Bhd is setting up a new manufacturing facility on a newly leased 3.06-acre tract in Batu Kawan Industrial Park in Seberang Perai Selatan, Pulau Pinang.

The initial public offering (IPO)-led rerating of the local healthcare sector could extend beyond hospitals in 2026, with the potential listings of several mega-healthcare groups in 2026, says Hong Leong Investment Bank (HLIB) Research.

LAC Med Bhd (KL:LACMED), en route to list on the Main Market of Bursa Malaysia on Dec 10, is positioning itself not as another medical equipment distributor but as a specialist in high-value, highly specialised machines — a space dominated globally by only a handful of manufacturers. Th...

UMediC Group Bhd's outlook in the near term is expected to be impacted, among others, by the ringgit's strength against the US dollar.

UMediC集团（UMC，0256，创业板）2026财年首季（截至10月底）净赚178万令吉，同比减少3.58%。...

Analysts are split on prospects for UMediC Group Bhd (KL:UMC) after the medical device distributor and manufacturer kicks off its financial year ending July 31, 2026 (FY2026) with weaker first-quarter results.

UMediC集团（UMC，0256，创业板）2026财政年首季（截至10月底）净赚178万令吉，同比减少3.58%。...

PENANG-based integrated engineering solutions provider UWC Bhd (KL:UWC) is positioning itself for the next phase of growth in the semiconductor cycle. This involves moving deeper into the front-end wafer fabrication equipment space, the initial, most complex and most capital-intensive stage of se...

UWC公司（UWC,5292,主板科技组）放眼将精密机械加工、组件组装、测试验证及供应链管理完整整合，并与全球领先半导体客户共同研发新工艺和新材料，推动下一代晶片制造技术的商业化落地。这也是UWC公司创办人、执行董事兼集团首席执行员拿督斯里黄才荣多年来坚持的转型与多元化之路。这代趋势：AI 下代趋势：晶片制作黄才荣认为电脑化和电子化是世界新发展的必然趋势，这一代的世界趋势是人工智能（AI），下一代为晶片制作，而企业要跟着潮流跑。他受访时说，UWC公司未来一年的发展新方向，是扩大组装与测试...

UMediC Group Bhd's entry into new markets in Latin America as well as rising order volumes from existing customers will bode well for the group, says Hong Leong Investment Bank (HLIB) Research.

PETALING JAYA: Medical device manufacturer UMediC Group Bhd's profit forecasts for the financial year ending July 31, 2026 (FY26) and FY27 have been raised by 16% and 12%, respectively, by Hong Leong Investment Bank Research.

券商 ：丰隆投行研究投资建议 ：守持目标价 ：36仙闭市价 ：38仙（截至9月12日）每股收益 ：2.3仙 （2026财年估计）本益比 ：16.3 倍 （2026财年估计）UMediC集团（UMC，0256，主要板医疗保健）2025财年末季的业绩表现不俗，我们将2026财年至2027财年的财测分别上调了16%及12%，主要反映公司分销业务较高的税前盈利预期。UMediC集团末季核心税后盈利（PATMI）报290万令吉（按季增60%，按年则跌6.2%），全年净利累计820万令吉，按...

KUALA LUMPUR: UMediC Group Bhd’s (UMC) sales volume for respiratory products in its manufacturing arm is expected to benefit from global healthcare megatrends, particularly the rise in the ageing population.

（吉隆坡11日讯）医疗服务供应商的需求下跌，拖累UMediC集团（UMC,0256,主板医疗保健组）截至2025年7月31日第四季净利减少17.97%至249万3000令吉。全年净利下跌9.54%，报813万3000令吉。第四季营业额减低17.38%，报1229万令吉；全年营业额也下滑11.01%，减至4856万4000令吉。根据UMediC集团的业绩报告，该公司第四季税前盈利减少6.61%，跌至379万令吉。公共、私人医疗和医疗服务供应商对医疗器材的需求下跌，冲击行销和批发业务，拖累营...

Phillip Research is optimistic about the prospects of UMediC Group Bhd which is pressing ahead with an expansion strategy that is set to reshape its earnings profile over the next two years.

KUALA LUMPUR: Here is a recap of the announcements that made headlines in Corporate Malaysia.